Redefining Role of 5-Fluorouracil and Exploring the Impact of Taxanes and Cisplatin in Locally Advanced and Recurrent Carcinoma Cervix in Concurrent Setting With Radiotherapy: A Literature Review
- PMID: 33376656
- PMCID: PMC7755651
- DOI: 10.7759/cureus.11645
Redefining Role of 5-Fluorouracil and Exploring the Impact of Taxanes and Cisplatin in Locally Advanced and Recurrent Carcinoma Cervix in Concurrent Setting With Radiotherapy: A Literature Review
Abstract
Cervical carcinoma is the fourth most frequent cancer among women worldwide while it is common in rural India. The irony of the situation is that it continues to present in a locally advanced stage with bulky disease posing a significant challenge to the current treatment modalities despite various screening programs. Concurrent chemoradiotherapy is the mainstay of treatment for locally advanced carcinoma cervix. However, the appropriate dosing schedules, along with the salutation of the chemotherapeutic agent, remain a matter of debate to date. The use of chemotherapy in the neoadjuvant and adjuvant setting promises to improve progression-free survival and overall survival. The article aims to review various chemotherapy and their regimens in the treatment of carcinoma of the cervix.
Keywords: 5-fu; carcinoma cervix; chemotherapy agents; cisplatin; concomitant chemo-radiation therapy; paclitaxel; radio sensitization.
Copyright © 2020, Kaur et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.Dis Esophagus. 2017 Jul 1;30(7):1-7. doi: 10.1093/dote/dox015. Dis Esophagus. 2017. PMID: 28475724
-
Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study.BMC Cancer. 2022 Dec 20;22(1):1331. doi: 10.1186/s12885-022-10406-9. BMC Cancer. 2022. PMID: 36539745 Free PMC article. Clinical Trial.
-
Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1226-32. doi: 10.1016/s0360-3016(02)04405-x. Int J Radiat Oncol Biol Phys. 2003. PMID: 12654431 Clinical Trial.
-
The Evolving and Future Role of Taxanes in Squamous Cell Carcinomas of the Head and Neck: A Review.JAMA Otolaryngol Head Neck Surg. 2016 Sep 1;142(9):898-905. doi: 10.1001/jamaoto.2016.1238. JAMA Otolaryngol Head Neck Surg. 2016. PMID: 27389786 Review.
-
Combined-modality therapy of locally advanced cervical cancer.J Clin Oncol. 2003 May 15;21(10 Suppl):211s-217s. doi: 10.1200/JCO.2003.01.222. J Clin Oncol. 2003. PMID: 12743137 Review.
Cited by
-
Data-Driven Modelling of Substituted Pyrimidine and Uracil-Based Derivatives Validated with Newly Synthesized and Antiproliferative Evaluated Compounds.Int J Mol Sci. 2024 Aug 29;25(17):9390. doi: 10.3390/ijms25179390. Int J Mol Sci. 2024. PMID: 39273338 Free PMC article.
-
A Comprehensive Review of Genistein's Effects in Preclinical Models of Cervical Cancer.Cancers (Basel). 2023 Dec 20;16(1):35. doi: 10.3390/cancers16010035. Cancers (Basel). 2023. PMID: 38201463 Free PMC article. Review.
References
-
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Bray F, Ferlay J, Soerjomataram I, et al. Cancer. 2018;68:394–424. - PubMed
-
- A review of cervical cancer: incidence and disparities. Buskwofie A, David-West G, Clare C. J Natl Med Assoc. 2020;112:229–232. - PubMed
-
- Global patterns of cancer incidence and mortality rates and trends. Jemal A, Center MM, DeSantis C, et al. Cancer Epidemiol Biomarkers Prev. 2010 Aug;19:1893–1907. - PubMed
Publication types
LinkOut - more resources
Full Text Sources